Misuse of Anticholinergic Medications: A Systematic Review
- PMID: 35203563
- PMCID: PMC8962297
- DOI: 10.3390/biomedicines10020355
Misuse of Anticholinergic Medications: A Systematic Review
Abstract
(1) Background: Over the last decade, misuse and diversion of medications has appeared to be increasingly concerning phenomena, including a range of different molecules. As current knowledge on the abuse of centrally acting anticholinergics is limited, the aim of the present study is to review the relevant published data, focusing on the following molecules: benztropine, biperiden, scopolamine, orphenadrine, and benzhexol/trihexyphenidyl (THP). (2) Methods: A systematic literature review was carried out using Pubmed, Scopus, and Web of Science databases following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Research methods were registered on PROSPERO (CRD42021257293). (3) Results: A total of 48 articles, including case reports, surveys, and retrospective case series analyses, were included. Most articles focused on benzhexol/THP (n = 25), and benztropine (n = 4). The routes of administration were mostly oral, and macrodoses together concomitant illicit drugs, e.g., cocaine, have been recorded. Toxidromes included both physical (e.g., tachycardia, tachypnoea, dilatated pupils, dry skin, urinary retention, ataxia, etc.) and psychiatric symptoms (e.g., anxiety, agitation, delirium, etc.). Fatal outcomes were very rare but reported. (4) Conclusion: Results from the present study show that anticholinergic misusing issues are both widespread worldwide and popular. Considering the potential adverse effects associated, healthcare professionals should be vigilant and monitor eventual misusing issues.
Keywords: anticholinergic drugs; drug abuse; drug diversion; drug misuse.
Conflict of interest statement
F.S. was a member of the UK Advisory Council on the Misuse of Drugs (ACMD; 2011–2019) and is currently a member of the EMA Advisory Board (Psychiatry). J.C. is a member of the ACMD’s Novel Psychoactive Substances and Technical Committees. G.M. has been a consultant and a speaker and has received research grants from Angelini, Doc Generici, Janssen-Cilag, Lundbeck, Otsuka, Pfizer, Servier, and Recordati. S.C., A.M. (Alessio Mosca), F.D.C., G.M., M.P., A.Mi. (Andrea Miuli), A.G., and F.S. (Francesco Semeraro) have nothing to declare. M.D.G. has been a consultant and a speaker and has received research grants from Angelini, Janssen-Cilag, Lundbeck, Otsuka, Pfizer, Servier, and Recordati.
References
-
- Chiappini S., Guirguis A., Corkery J.M., Schifano F. Misuse of prescription and over-the-counter drugs to obtain illicit highs: How pharmacists can prevent abuse. Pharm. J. 2020;305:1–31.
-
- European Monitoring Centre for Drugs and Drug Addiction Non-Medical Use of Medicines: Health and Social Responses [Internet] 2021. [(accessed on 24 December 2021)]. Available online: https://www.emcdda.europa.eu/publications/mini-guides/non-medical-use-of....
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
